Kiadis Pharma NV KDS-NL:Euronext Amsterdam

*Data is delayed | EUR
Last | 10:23 AM CET
5.41quote price arrow up+0.01 (+0.09%)
Volume
69,761
52 week range
1.25 - 5.42

...

Loading . . .

KEY STATS

  • Open5.41
  • Day High5.42
  • Day Low5.41
  • Prev Close5.40
  • 52 Week High5.42
  • 52 Week High Date03/01/21
  • 52 Week Low1.25
  • 52 Week Low Date04/03/20
  • Market Cap261.85M
  • Shares Out40.04M
  • 10 Day Average Volume172,151.2
  • Dividend-
  • Dividend Yield-
  • Beta5.95
  • 1 Year % Change191.85

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-3.67
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kiadis Pharma NV News

There is no recent news for this security.

Latest KDS-NL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kiadis Pharma NV is a biopharmaceutical company based in the Netherlands. It focuses on development of therapies for patients with life-threatening diseases. Its programs consist of off-the-shelf and haploidentical donor NK-cell therapy products for the treatment of liquid and solid tumors as adjunctive and stand-alone therapies. Its PM21 particle technology enables ex vivo expansion and activation of cytotoxic NK cells supporting multiple high-dose infusions. Its...
Arthur Lahr
Chief Executive Officer
Address
Paasheuvelweg 25A
Amsterdam
1105 BP
Netherlands